Appointments and advancements for July 27, 2026
AI Briefing
- Abivax appoints new CEO, replacing outgoing CEO since 2018.
- GE promotes several executives to lead new biopharma divisions.
- Neurocrine names former Pfizer executive as new chief commercial officer.
Source Summary
New hires and promotions in the biopharma and med-tech industries, including: Abivax, GE, Neurocrine, Tessera, Vir.
Advertisement